Connection

Jiangning Liu to Treatment Outcome

Back to Details
This is a "connection" page, showing publications Jiangning Liu has written about Treatment Outcome.
Jiangning Liu
Connection Strength
0.015
Treatment Outcome
  1. Therapeutic efficacy of Pudilan Xiaoyan Oral Liquid (PDL) for COVID-19 in vitro and in vivo. Signal Transduct Target Ther. 2020 05 08; 5(1):66.
    View in: PubMed
    Score: 0.008
  2. GS-9620 inhibits enterovirus 71 replication mainly through the NF-?B and PI3K-AKT signaling pathways. Antiviral Res. 2018 05; 153:39-48.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.